Dr Reddys Stock Target Price and Analyst Consensus

RDY
 Stock
  

USD 55.84  0.45  0.81%   

The current analyst and expert consensus on Dr Reddys is Hold, with 0 strong sell and 1 strong buy opinions. The current projected Dr Reddys target price consensus is 48.95 with 2 analyst opinions. The most common way Dr Reddys Laboratories analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Dr Reddys executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Dr Reddys. We encourage you to use your own analysis of Dr Reddys Laboratories to validate this buy or sell advice. Dr Reddys buy-or-sell recommendation module provides average expert sentiment on the projected Dr Reddys Laboratories target price to derive its highest and lowest estimates based on projected price volatility of 9.97. Additionally, take a look at Macroaxis Advice on Dr Reddys to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh

Dr Reddys Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Dr Reddys target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Dr Reddys target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions2
Lowered Outlook0
Raized Outlook0
Hold
Most Dr Reddys analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Dr Reddys stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Dr Reddys Laboratories, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Dr Reddys Target Price Projection

Dr Reddys' current and average target prices are 55.84 and 48.95, respectively. The current price of Dr Reddys is the price at which Dr Reddys Laboratories is currently trading. On the other hand, Dr Reddys' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Dr Reddys Market Quote on 4th of July 2022

Low Price55.01Odds
High Price55.87Odds

55.84

Target Price

Analyst Consensus On Dr Reddys Target Price

Low Estimate41.9Odds
High Estimate56.0Odds
Number of Analysts2
Standard Deviation9.97

48.95

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Dr Reddys Laboratories and the information provided on this page.

Dr Reddys Analyst Ratings

Dr Reddys' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Dr Reddys stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Dr Reddys' financials, market performance, and future outlook by experienced professionals. Dr Reddys' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Dr Reddys Target Price Projections

Dr Reddys's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Dr Reddys Laboratories and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Dr Reddys depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Dr Reddys Laboratories including analysis of its current option contracts.
Dr Reddys' latest option contracts expiring on 2022-07-15 are carrying combined implied volatility of 62.35 with a put-to-call open interest ratio of 0.0 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2022-07-15. The current put volume is at 0, with calls trading at the volume of 1. This yields a 0.0 put-to-call volume ratio. The Dr Reddys option chain provides detailed quote and price information for the current Dr Reddys Laboratories option contracts. It shows all of Dr Reddys' listed puts, calls, expiration dates, strike prices, and other pricing information.
Dr Reddys' stock options are financial instruments that give investors the right to buy or sell shares of Dr Reddys Laboratories common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Dr Reddys stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Dr Reddys' stock price goes up or down, the stock options follow.
Additionally, take a look at Macroaxis Advice on Dr Reddys to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Dr Reddys Current Options Market Mood

Dr Reddys' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Dr Reddys Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Most options investors, including buyers and sellers of Dr Reddys' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Dr Reddys' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Dr Reddys' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Dr Reddys Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Dr Reddys is a key component of Dr Reddys valuation and have some predictive power on the future returns of a Dr Reddys.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Dr Reddys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Dr Reddys in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
54.0855.8457.60
Details
Intrinsic
Valuation
LowReal ValueHigh
50.1451.9061.42
Details
Naive
Forecast
LowNext ValueHigh
56.0357.7959.55
Details
Earnings
Estimates (2)
LowProjected EPSHigh
1.251.261.28
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Dr Reddys. Your research has to be compared to or analyzed against Dr Reddys' peers to derive any actionable benefits. When done correctly, Dr Reddys' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Dr Reddys Laboratories.

Additional Dr Reddys Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Dr Reddys is a key component of Dr Reddys valuation and have some predictive power on the future returns of a Dr Reddys.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Dr Reddys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Dr Reddys in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
54.0855.8457.60
Details
Intrinsic
Valuation
LowReal ValueHigh
50.1451.9061.42
Details
Naive
Forecast
LowNext ValueHigh
56.0357.7959.55
Details
Earnings
Estimates (2)
LowProjected EPSHigh
1.251.261.28
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Dr Reddys. Your research has to be compared to or analyzed against Dr Reddys' peers to derive any actionable benefits. When done correctly, Dr Reddys' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Dr Reddys Laboratories.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investor Favorites
Invested less than 1 share
Macroaxis Index
Invested few shares
Technology
Invested few shares
Additionally, take a look at Macroaxis Advice on Dr Reddys to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Dr Reddys Stock analysis

When running Dr Reddys Laboratories price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
The data published in Dr Reddys' official financial statements usually reflect Dr Reddys' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Dr Reddys Laboratories. For example, before you start analyzing numbers published by Dr Reddys accountants, it's critical to develop an understanding of what Dr Reddys' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Dr Reddys' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Dr Reddys' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Dr Reddys' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Dr Reddys Laboratories. Please utilize our Beneish M Score to check the likelihood of Dr Reddys' management to manipulate its earnings.